All Insights

Commercial

Marketinglaw update | December 2022

Welcome to the latest edition of Marketinglaw.
Employment and pensions

UK Pensions Regulator consults on new defined benefit funding code

The draft code, fast-track parameters and proposed regulatory approach have been released for industry feedback
The Built Environment

Overview of environmental obligations in real estate transactions in Flanders

Since 23 November 2022, an asbestos certificate is required when selling homes or buildings built before 2001. By 2032, every
The Built Environment

Overzicht van milieuverplichtingen bij vastgoedtransacties in Vlaanderen

Sinds 23 november 2022 is een asbestattest verplicht bij de verkoop van woningen en gebouwen gebouwd voor 2001. Tegen 2032
Life Sciences and Healthcare

Products without an intended medical purpose: EU clarifies conditions

Non-medical product manufacturers have limited time to prepare for new risk management and clinical data obligations
Financial Services

VC Focus | Is there a 'market standard' distribution waterfall for international VC funds?

There are a range of alternatives to the distribution waterfall model available for venture capital firms
Retail and Consumer

Poland's Office of Competition and Consumer Protection investigates 'dark patterns'

Entrepreneurs can be fined up to 10% of their turnover for violating the collective interests of consumers
Energy and Utilities

The Energy Transition | UK government updates hydrogen strategy

This week we look at the government's hydrogen strategy, the world's first carbon tariff, Ofgem's decision on CLASS balancing services
Real estate

Business rates in 2023 to shake up statutory compensation in UK lease renewals

Changes to rateable values will affect what is payable when terminating leases under the Landlord and Tenant Act 1954
Corporate

What would Labour do? The 'Start-up review': future policy on UK venture capital, tax incentives, and access to capital

'Start-up review', while not official policy, indicates Labour's thinking on the role of venture capital in stimulating growth
Life Sciences and Healthcare

The UK Patents Court puts an arrow through Teva's application for declaratory relief

Court of Appeal makes clear the limits on obtaining Arrow declaratory relief for deployment in other jurisdictions